NapiƱas, Victoria S.
HRN: 16-33-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
CEFTRIAXONE 1G (VIAL)
03/25/2025
04/01/2025
IV
2gm
OD
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes